Human Microbiome Market to Reach $3.9 Billion by 2035

Human microbiome market was valued at $1.6 billion in 2025 and is projected to reach $3.9 billion by 2035, expanding at a CAGR of 9.7%. A major growth driver is the rising prevalence of chronic diseases worldwide. According to the account for nearly 74% of global deaths, increasing the need for preventive and long-term healthcare solutions. This trend is significantly boosting demand for microbiome-based interventions such as probiotics, prebiotics, and personalized nutrition. Growing awareness of gut health and its link to immunity and metabolic disorders is further supporting market expansion. Additionally, advancements in microbiome research and precision medicine are enabling targeted therapeutic approaches. As a result, the market is witnessing steady growth across both clinical and consumer health segments.

Browse the full report description of “Human Microbiome Market Size, Share & Trends Analysis Report By Product Type (Probiotics, Prebiotics, Synbiotics, Postbiotics, Others), By Technology (Prebiotics Sequencing, Metabolomics, Proteomics, bioinformatics and AI-based Analysis, Microbial Culturing), By Application (Therapeutics, Preventive Healthcare & Wellness, Diagnostics & Biomarker Discovery, Personalized Nutrition, Cosmetics & Dermatology), and Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/human-microbiome-market

Microbiome Innovators Unlock Next-Gen Therapeutics Transforming Human Health

Leading companies such as Seres Therapeutics, Ferring Pharmaceuticals, and Vedanta Biosciences are driving breakthroughs in the human microbiome market through advanced live biotherapeutics and precision microbial consortia. Their focus on targeted, disease-modifying therapies is reshaping treatment paradigms across gastrointestinal, metabolic, and immune-related disorders. Strategic partnerships and expanding clinical pipelines are accelerating innovation, positioning microbiome-based solutions as a transformative force in modern medicine.

• In February 2026, Nestlé announced new research highlighting the role of NAD+ supplementation in improving cellular energy and gut microbiome health. The findings demonstrate that NAD+ boosters can promote beneficial microbial activity and metabolite production, supporting healthy aging. This research is expected to guide the development of next-generation microbiome-based nutrition solutions and strengthen innovation in preventive healthcare.

• In August 2025, Danone announced the acceleration of its Renew transformation strategy, restructuring operations to enhance agility and expand its health and nutrition focus. The initiative emphasizes growth in gut health and functional nutrition segments, which are closely linked to microbiome science. By strengthening its global structure and innovation capabilities, the company aims to advance microbiome-based nutrition and preventive healthcare solutions.

• In April 2024, DSM-Firmenich and Lallemand Health Solutions announced a strategic partnership to launch synergistic synbiotic solutions for early-life nutrition. The solutions combine human milk oligosaccharides (HMOs) with probiotics to support the development of the infant gut microbiome and immune health. The innovation aims to mimic the microbiome composition of breastfed infants, highlighting growing advancements in microbiome-based nutrition solutions.

Market Coverage

• The market number available for – 2025–2035
• Base year – 2025
• Forecast period – 2026–2035
• Segment Covered-
• By Product Type
• By Technology
• By Application
• Regions Covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Competitive Landscape: Nestlé Health Science, ADM, BASF, Danone, DSM-Firmenich, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Human Microbiome Market Report Segment

By Product Type

• Probiotics
• Prebiotics
• Synbiotics
• Postbiotics
• Others

By Technology

• Prebiotics Sequencing Technologies
• Metabolomics
• Proteomics
• Bioinformatics & AI-based Analysis
• Microbial Culturing Technologies

By Application

• Therapeutics
• Preventive Healthcare & Wellness
• Diagnostics & Biomarker Discovery
• Personalized Nutrition
• Cosmetics & Dermatology.

Global Human Microbiome Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/human-microbiome-market